Uzbekistan’s pharmaceutical market has been expanding at an unprecedented pace in recent years. By the end of 2024, the market volume reached 24.8 trillion UZS, recording 19% annual growth. In 2023–2024, Uzbekistan’s pharma sector became one of the fastest-growing segments in the CIS: total retail sales increased by 13% to 20.3 trillion UZS. The number of pharmacies is also rising sharply—from around 10.7 thousand in 2018 to over 15.8 thousand by 2022—meaning the market expanded by more than 1.5 times in just four years.
At the same time, the sector remains heavily dependent on imports. As of 2025, more than 89% of the market value consists of imported medicines. Although domestic pharmaceutical production grew 1.9 times between 2017 and 2024, it still cannot fully meet overall market demand. While digitalization has begun, much of the industry continues to rely on analog management, fragmented databases, and non-standardized processes.
This coexistence of rapid growth and deep structural constraints makes the pharmaceutical sector both highly dynamic and systematically vulnerable. Crucially, these challenges not only hinder sustainable development but also create large innovation gaps for PharmaTech and HealthTech startups.
This article provides a professional analysis of 11 key pain points in Uzbekistan’s pharmaceutical ecosystem and the technology-driven startup directions capable of addressing them.
1. Market Data Uncertainty — A Strategic Opportunity for DataTech
Data quality in the pharmaceutical market remains low: sales dynamics are poorly classified, demand forecasts are inaccurate, and inventory planning is frequently disrupted. Pharmacies often procure “by intuition,” leading to overstocking or shortages.
Startup solutions:
- Real-time market analytics platforms
- AI-based demand forecasting
- Growth/decline indicators by product category
While this space is already well developed globally, Uzbekistan still lacks a professional DataTech player.
2. Non-Compliance with GPP Standards — Demand for Digital Compliance Services
Many pharmacies fail to comply with Good Pharmacy Practice (GPP) standards. Modernization costs are high, and inspections expose businesses to additional risks.
Startup solutions:
- Digital GPP compliance scoring
- Automated audit systems
- Real-time GPP monitoring for pharmacies
This segment is virtually empty in the local ecosystem.
3. Absence of a Unified Reference System — The Unified Pharma Catalog Opportunity
Confusion around IKPU/MXIK/ATC codes is one of the sector’s most serious technical problems. Different ERP, POS, and warehouse systems are incompatible, and medicine databases are constantly error-prone.
Startup solutions:
- A unified drug catalog with a single identifier
- Data mapping and conversion engines
- API integrations between manufacturers, distributors, and pharmacies
Such a solution could scale beyond Uzbekistan and become exportable across Central Asia.
4. Opaque Marketing Contracts — The Pharma Marketplace Model
Today, manufacturers allocate marketing budgets primarily through large pharmacy chains, leaving small pharmacies outside the process.
Startup solutions:
- Open marketing marketplaces for all pharmacies
- Transparent tender models for manufacturers
- Analytics modules measuring promo campaign effectiveness
A platform that democratizes competition could transform the entire sector.
5. Counterfeit Products — The Anti-Counterfeit Technology Market
Illicit medicines lead to dumping, loss of brand trust, and safety risks. Existing control mechanisms do not operate in real time.
Startup solutions:
- Mobile apps for QR-based authenticity verification
- Blockchain systems tracking product movement
- Platforms enabling informed decisions for pharmacies and consumers
Globally, this is one of the fastest-growing HealthTech segments.
6. Complexity of Drug Marking — ScanTech Innovations
Errors in the marking process can halt sales, increase inspections, and result in products being withdrawn from circulation.
Startup solutions:
- AI-based detection of scanning errors
- Systems optimizing scanning speed
- Real-time dashboards tracking marking status
Although highly technical, this segment represents a very large market.
7. Workforce Shortages — A Major Opportunity for EdTech
The shortage of qualified pharmacists is worsening. Reduced shifts negatively affect service quality.
Startup solutions:
- Micro-learning platforms for pharmacists
- AR/VR-based practical training programs
- Automated corporate learning systems for pharmacy chains
Demand is rising rapidly, while supply remains minimal.
8. Low Staff Qualifications and Service Skills — Innovations to Improve Service Quality
Many pharmacy employees lack strong pharmacological knowledge and client-needs assessment skills.
Startup solutions:
- Interactive pharmacology courses
- AI-based sales training assistants
- Continuous certification mechanisms
These tools can significantly improve customer loyalty.
9. High Dependence on Imports — Supply Chain Digitalization Startups
Currency volatility, delayed deliveries, and stock shortages are direct consequences of import dependency.
Startup solutions:
- ERP-light solutions for local manufacturers
- Digital supply chain platforms
- Smart procurement systems
Such innovations enhance efficiency while stabilizing prices.
10. Prescription-Only Medicines — The Need for an E-Prescription Ecosystem
Pharmacy staff often face a dilemma between legal requirements and customer expectations. A full electronic prescription system can resolve this conflict.
Startup solutions:
- Doctor–pharmacy system integrations
- Unified e-prescription platforms
- Automated drug interaction and alert systems
Globally, this has already become a multi-billion-dollar market.
11. Low Margins and Price Controls — AI-Driven Profitability Solutions
Reference pricing and low markups severely limit pharmacy profits. Growth without operational efficiency is nearly impossible.
Startup solutions:
- Category management systems
- Dynamic pricing algorithms
- AI-based profitability optimization platforms
For pharmacies, technology is the only sustainable path to revenue stability. Today, Uzbekistan’s pharmaceutical sector faces numerous systemic barriers. Yet these same barriers represent:
- Open segments for new startup ideas
- High-ROI opportunities for investors
- New growth avenues for the ecosystem
If fintech has been Uzbekistan’s fastest-growing sector over the past five years, the next wave belongs to PharmaTech. The combination of rapid market growth and unresolved structural gaps positions this sector as one of the most promising startup markets in the years ahead.
If you have solutions to these challenges, get in touch: https://t.me/pharma_next
Gulnoza Mikhailovna
